A software-implemented process for preventing reuse of a replaceable cleansing attachment includes detecting, via a chip in the replaceable cleansing attachment, that the replaceable cleansing attachment is attached to a base. The method also includes during a first use, receiving, at an acoustic transducer, high-frequency current from the base, wherein the acoustic transducer converts the high-frequency current into sound waves to assist in an abrasive removal of wound coatings. And the method includes recording, to the chip, an indication of the first use of the replaceable cleansing attachment, wherein the chip is configured to prevent a second use of the replaceable cleansing attachment when the chip has the indication of first use of the replaceable cleansing attachment stored thereon.

A method for treating an oral cavity malady of a patient, comprising: applying a spot of a laser beam to a target area around the oral cavity, said laser beam having a wavelength of about 800 to 840 nm and a power of between 1000 and 4000 mW, and wherein said spot has a spot size of about 1 to about 10 mm; and moving said spot on said target area for a treatment time sufficient to deliver a dose of about 0.5 to about 30 J/cm.sup.2 to said target area.

A device that is connectable to a phototherapy apparatus for applying targeted phototherapy to an area of skin to place a skin condition into remission and a method of determining a maximum tolerable dose of phototherapy applied to a treatment area to determine an optimum therapeutic dose to quickly place a skin condition into remission. The dosimetry device can include a housing and an optical matrix arranged within the housing. The optical matrix includes a plurality of at least one of absorptive, reflective and/or partially transmissive regions that each permits a different percentage of light to be delivered to an individual's skin. An assessment can then be made as to the maximum tolerable dose of phototherapy that can be applied to the individual's skin in order to place a skin condition into remission.

The skin therapy device combines the mechanical stimulation and cleansing in the form of vibration with optical stimulation from LEDs. The device combines these two elements without sacrificing the effectiveness of either the mechanical cleansing/stimulation or optical stimulation by passing the light through the mechanical elements that are in contact with the skin. The light from the LEDs does not pass around the mechanical elements, such as around opaque brush fibers, but passes through the mechanical elements.

A computerized method for controlling the operation of a laser therapy device is disclosed. A laser therapy device comprising laser diodes has a microprocessor for storing and executing instructions pertaining to the operation of the laser diodes within certain parameters. The computerized method detects the movement of the laser therapy device and alters the output of the laser diodes when a movement signal exceeds predetermined threshold parameters. The computerized method detects difference in temperature in certain areas, and patterns in temperature differences, for assistance in diagnosing ailments. The computerized method also detects differences in skin color to determine treatment areas. The computerized method also measures the distance of the laser therapy device to a treatment area. The microprocessor executes instructions then which can alter the output of the laser diodes or generate an alarm signal based on measurements received.

Multi-modal, portable, handheld devices for tissue assessment (e.g., wound assessment) are provided, as are methods of fabricating and methods of using the same. The devices can be used for virtual medicine (VM)-based wound management, such as VM-based diabetic foot triage (DFT) and management. The device can be used to take physiological measurements of temperature and/or tissue oxygenation of a wound to assess the wound, for example in a remote setting environment. The device can also be used to provide therapy for tissue repair and/or wound healing, apart from the multi-modal imaging of the tissue surface of the patient. For example, light therapy, such as low-level light therapy (LLLT) can be provided via one or more light emitting diodes (LEDs) and/or laser diodes.

A cold plasma system and method for treating a region of a biological surface is presented. In one embodiment, the system includes: a housing; an air conduit within the housing; a first electrode configured proximately along the air conduit; a second electrode configured proximately along the air conduit and opposite from the first electrode; and a source of alternating current (AC) electrically connected with the first electrode. The source of alternating current is configured to generate cold plasma in the air conduit.

A device for enhancement of visual appearance including a first applicator to be coupled to a first area of a body region, with a first magnetic field generating device and a first radiofrequency electrode, a second applicator to be coupled to a second area of the body region, with a second magnetic field generating device. The device further includes a first energy storage device, a second energy storage device, and a first switching device to discharge energy from the first energy storage device to the first magnetic field generating to generate a first time-varying magnetic field to cause muscle contraction, and a second switching to discharge energy from the second energy storage device to the second magnetic field generating device to generate a second time-varying magnetic field. The first radiofrequency electrode may provide first radiofrequency waves causing heating of tissue within the first area of the body region.

Respiratory function can be preserved and/or enhanced in patients with a respiratory insufficiency using a photoceutical applied by a photoceutical medical device to at least one primary inspiratory muscle and/or a lung. At least one site on a body of a patient can be selected for delivery of the photoceutical to the muscle(s); and the photoceutical can be applied at the at least one site by the photoceutical medical device for a time period from a first start time to a first end time to treat the at least one primary inspiratory muscle and/or the lung of the patient to preserve and/or enhance the respiratory function. The photoceutical can include a light signal with at least one delivery scheme (e.g., superpulsed, pulsed. and/or continuous) and one or more wavelengths.

An optical therapeutic device comprising a front body portion, a light source provided in said front body portion, a spherical, translucent quartz lens provided in front of said light source, a bezel provided on said front body portion and configured to hold said spherical, translucent quartz lens such that a portion of the quartz lens protrudes outside the rim of the bezel. Also described is a method of using the device to apply light stimulation to acupuncture points of a human or animal body and a method for manufacturing the device.